Pulse Biosciences is a development-stage medical device company using a novel and proprietary platform technology called Nano-Pulse Stimulation or NPS. NPS is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue. We believe that NPS can induce a variety of cellular responses including secretion, apoptosis and necrosis by modulating the NPS pulses, making it applicable to a wide variety of cell types and therapeutic applications. One of the more promising applications of NPS is the treatment o
Pulse Biosciences Quarterly Investor Conference Call Tue, 07 Nov 2017 21:22:00 +0000 Pulse Biosciences, Inc. , a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform, today reports recent corporate developments and financial results for the quarter ended September 30, 2017.
Pulse Biosciences, Inc. to Host Earnings Call Tue, 07 Nov 2017 15:00:00 +0000 NEW YORK, NY / ACCESSWIRE / November 7, 2017 / Pulse Biosciences, Inc. (NASDAQ: PLSE ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 7, 2017 at 4:30 PM Eastern ...
Pulse Biosciences to Host Quarterly Investor Conference Call on November 7, 2017 Tue, 24 Oct 2017 21:00:00 +0000 Pulse Biosciences, Inc., a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform, today announced it will host its quarterly investor conference call on Tuesday, November 7, 2017 at 1:30 p.m.
Healthcare Industry Trends And Its Impact On Pulse Biosciences Inc (PLSE) Sun, 15 Oct 2017 17:37:15 +0000 Pulse Biosciences Inc (NASDAQ:PLSE), a USD$399.35M small-cap, operates in the healthcare industry, which has experienced tailwinds from issues such as higher demand driven by an aging population and the increasingRead More...
Pulse Biosciences Announces $30 Million Private Placement Mon, 25 Sep 2017 12:00:00 +0000 Pulse Biosciences, Inc. , a medical technology company developing a proprietary therapeutic tissue treatment based on its Nano-Pulse Stimulation platform, today announced that it has entered into a stock purchase agreement with Robert W.
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.